Lv1
40 积分 2023-07-08 加入
Proviral DNA as a Target for HIV-1 Resistance Analysis
1个月前
已完结
Minor viral population with drug-resistant mutation and risk of persistent low-level viremia or ‘blips’ in HIV-1 subtype C
1个月前
已完结
Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes
1个月前
已完结
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018
3个月前
已完结
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA
6个月前
已完结
Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia
6个月前
已关闭
The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study
8个月前
已完结
Two-drug regimens with dolutegravir plus rilpivirine or lamivudine in HIV-1 treatment-naïve, virologically-suppressed patients: Latest evidence from the literature on their efficacy and safety
9个月前
已完结
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians
9个月前
已完结
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians
10个月前
已完结
皖公网安备34019202002308
